Literature DB >> 7492168

Management of infantile polyposis syndrome.

G J Stiff1, A Alwafi, H Jenkins, J Lari.   

Abstract

A boy with generalised infantile polyposis syndrome is reported to highlight the difficulties in management. Despite attempts to reduce polyp mass by regular endoscopic polypectomy, daily transfusions of blood products, and a trial of the non-steroidal anti-inflammatory agent sulindac, his condition gradually deteriorated and he died of septicaemia.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7492168      PMCID： PMC1511283          DOI： 10.1136/adc.73.3.253

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  JUVENILE POLYPOSIS COLI.

Authors:  I MCCOLL; H J BUSXEY; A M VEALE; B C MORSON
Journal:  Proc R Soc Med       Date:  1964-10

2.  Polyps of the rectum and colon in children.

Authors:  E G HORRILLENO; C ECKERT; L V ACKERMAN
Journal:  Cancer       Date:  1957 Nov-Dec       Impact factor: 6.860

3.  Juvenile gastrointestinal polyposis in a female infant: report of a case and review of the literature of a recently recognized syndrome.

Authors:  C R Sachatello; I S Hahn; C B Carrington
Journal:  Surgery       Date:  1974-01       Impact factor: 3.982

4.  Sulindac for polyposis of the colon.

Authors:  W R Waddell; G F Ganser; E J Cerise; R W Loughry
Journal:  Am J Surg       Date:  1989-01       Impact factor: 2.565

5.  Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

Authors:  K P Nugent; K C Farmer; A D Spigelman; C B Williams; R K Phillips
Journal:  Br J Surg       Date:  1993-12       Impact factor: 6.939
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.